Background Previous epidemiological studies demonstrated that premature atrial contractions (PACs) and premature ventricular ...

Jaypirca (pirtobrutinib) improved progression-free survival in treatment-naïve patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) when compared with bendamustine ...

Jaypirca is approved for the treatment of adults with relapsed or refractory CLL/SLL who were previously treated with a ...

Irregular heartbeats can signal AFib. Early detection and appropriate treatments help manage it and protect long-term heart health.

Researchers said future studies could help refine the use of Jaypirca alone or in combination with other therapies as a frontline treatment. She added that they are also continuing to investigate ...

Pirtobrutinib showed noninferiority in ORR compared to ibrutinib in BTK inhibitor-naive CLL/SLL patients, with a favorable PFS trend. Safety profiles indicated fewer adverse events with pirtobrutinib, ...

Contrary to old beliefs, a new study suggests daily coffee might help manage irregular heart rhythms like AFib. Researchers ...

Boston Scientific (NYSE: BSX) announced recently that it received CE mark for its Farapoint pulsed field ablation (PFA) ...

Boston Scientific has obtained an approval in Europe for the latest addition to its pulsed field ablation portfolio, with the ...

Imricor has completed the world’s first ischemic ventricular tachycardia ablation procedure under MRI. CEO Steve Wedan has bigger plans ahead.

Introduction Atrial fibrosis identified on cardiac magnetic resonance (CMR) imaging has been proposed as a preprocedural ...

Many adults with obstructive hypertrophic cardiomyopathy (oHCM) taking mavacamten experienced new atrial fibrillation or flutter, new-onset heart failure, and frequent acute care use within months of ...